Workflow
IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates
IRTCiRhythm(IRTC) ZACKS·2025-05-01 22:45

Company Performance - iRhythm Technologies reported a quarterly loss of 0.95pershare,whichwasworsethantheZacksConsensusEstimateofalossof0.95 per share, which was worse than the Zacks Consensus Estimate of a loss of 0.89, but an improvement from a loss of 1.47pershareayearago,indicatingayear−over−yearimprovement[1]−Thecompanypostedrevenuesof1.47 per share a year ago, indicating a year-over-year improvement [1] - The company posted revenues of 158.68 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.34% and showing an increase from 131.93millioninthesamequarterlastyear[2]−Overthelastfourquarters,iRhythmTechnologieshasexceededconsensusEPSestimatestwotimesandtoppedconsensusrevenueestimatesfourtimes[2]StockPerformance−iRhythmTechnologiesshareshaveincreasedbyapproximately18.5131.93 million in the same quarter last year [2] - Over the last four quarters, iRhythm Technologies has exceeded consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - iRhythm Technologies shares have increased by approximately 18.5% since the beginning of the year, contrasting with a decline of 5.3% in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is -0.55 on revenues of 171.04million,andforthecurrentfiscalyear,itis−171.04 million, and for the current fiscal year, it is -1.75 on revenues of $681.28 million [7] Industry Outlook - The Medical Info Systems industry, to which iRhythm Technologies belongs, is currently ranked in the top 18% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - The performance of iRhythm Technologies' stock may be influenced by the overall industry outlook, as empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions [5][8]